menu
    • menu

    Company profile for PTC Therapeutics

    NEW Drugs in Dev: 13
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission at PTC Therapeutics has always been to build an integrated biopharmaceutical company based on our expertise in RNA biology. We have focused on discovering and developing novel oral treatments for patients with serious and life-limiting disorders. By targeting the processes that modulate RNA biology and affect protein production, we bring an innovative approach to drug discovery. We are focused particularly on the d...
    Our mission at PTC Therapeutics has always been to build an integrated biopharmaceutical company based on our expertise in RNA biology. We have focused on discovering and developing novel oral treatments for patients with serious and life-limiting disorders. By targeting the processes that modulate RNA biology and affect protein production, we bring an innovative approach to drug discovery. We are focused particularly on the development and commercialization of treatments for rare and neglected disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PTC TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ
    Telephone
    Telephone
    + 908-222-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ptcbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ptc-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ptcbio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PTC Withdraws US Approval Filing For Duchenne Drug Translarna
    PTC Withdraws US Approval Filing For Duchenne Drug Translarna

    13 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/ptc-shuts-down-fda-approval-bid-troubled-duchenne-med-translarna

    FIERCE PHARMA
    13 Feb 2026
    Share Share
    PTC Therapeutics Provides Regulatory Update On Translarna
    PTC Therapeutics Provides Regulatory Update On Translarna

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-regulatory-update-on-translarna-302686879.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share
    PTC Therapeutics To Release Q4 And Full Year 2025 Financials
    PTC Therapeutics To Release Q4 And Full Year 2025 Financials

    05 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-thursday-feb-19-2026-302679246.html

    PR NEWSWIRE
    05 Feb 2026
    Share Share
    PTC Therapeutics Updates At J.P. Morgan Healthcare Conference
    PTC Therapeutics Updates At J.P. Morgan Healthcare Conference

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-update-at-jp-morgan-annual-healthcare-conference-302658410.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    PTC Therapeutics Issues Inducement Grants Under Nasdaq Rules
    PTC Therapeutics Issues Inducement Grants Under Nasdaq Rules

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302656185.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    PTC Therapeutics Gets Japan Approval For Sephience In (PKU)
    PTC Therapeutics Gets Japan Approval For Sephience In (PKU)

    22 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-approval-of-sephience-sepiapterin-for-the-treatment-of-children-and-adults-living-with-phenylketonuria-pku-in-japan-302647819.html

    PR NEWSWIRE BIO
    22 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search